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Conversion of tunneled hemodialysis catheter–consigned pa-
tients to arteriovenous fistula.
Objective. Despite their high incidence of complications,
costs, morbidity, and mortality, nearly 27% of the chronic
hemodialysis (HD) patients are receiving treatment via a tun-
neled hemodialysis catheter (TDC).
Methods. In this prospective analysis, an interventional
nephrology team employed an organized program consisting
of vascular access (VA) education and vascular mapping (VM)
to TDC-consigned patients. A full range of surgical approaches
for arteriovenous fistula (AVF) creation, including vein trans-
positions, was exercised. Physical examination was performed
every 1 to 2 weeks after surgery to assess the development of
the AVF. Fistulas that failed to develop adequately to support
HD (early failure) underwent salvage [percutaneous translu-
minal angioplasty (PTA), accessory vein obliteration (AVL)]
procedures.
Results. One hundred twenty-one TDC-consigned patients
received VA education. Eighty-six (71%) agreed to undergo
VM. Two groups were identified. Group I (N = 66; using TDC
for 7.2 ± 1.8 SD months) had never had an arteriovenous ac-
cess; group II (N = 20; using TDC for 12.3 ± 4.0 months) had
a history of one or more previously failed arteriovenous ac-
cesses. Upon VM, 64/66 (97%) in group I and 18/20 (90%) in
group II were found to have adequate veins for AVF creation.
Seven patients (11%) in group I and 3 (17%) in group II re-
fused surgery. In group I, 57 (89%) received an arteriovenous
access (radiocephalic AVF = 15, brachiocephalic AVF = 35,
transposed brachiobasilic AVF = 3, brachiobasilic AVG = 4).
In group II, 15 (83%) received a transposed AVF (radiobasilic
= 2, brachiobasilic = 13). Sixteen fistulas (30%) in group I and
8 (53%) in group II had early failure. All except for one fistula
in each group were salvaged using PTA and/or AVL. All 70 ac-
cesses (AVF = 66, AVG = 4) remain functional, with a mean
follow-up of 8.5 ± 3.6 months.
Conclusion. These results demonstrate that an organized
approach based upon a comprehensive program utilizing VA
counseling, VM, application of full range of surgical techniques,
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and salvage procedures can be very successful in providing op-
timum vascular access to the catheter-dependent patient.
The National Kidney Foundation-Dialysis Outcomes
Quality Initiative (NKF-DOQI) guidelines for vascular
access discourage the use of tunneled dialysis catheters
(TDCs) as long-term access for hemodialysis [1]. Al-
though these guidelines state that less than 10% of the
chronic dialysis patients should be maintained on tun-
neled dialysis catheters [2], recent data have emphasized
that up to 27% of the end-stage renal disease patients in
the United States are using TDC as their permanent ac-
cess [3, 4]. Of particular concern is the fact that the use
of TDCs as permanent dialysis access is steadily on the
rise, with placement rates having doubled since 1996 [3].
A variety of factors are responsible: the lack of vascu-
lar access counseling, delays in referral of patients with
advanced chronic kidney disease to nephrologists, lack
of timely surgical placement of an arteriovenous access
(fistula/graft), the logistic ease of inserting a vascular
catheter that is immediately available for use as compared
to the difficulties and delays associated with the success-
ful creation of an arteriovenous access, as well as patient
choice of a TDC owing to fear of pain associated with
needle insertion into arteriovenous accesses and cosmetic
concerns [1, 3, 4]. Another critical factor contributing to
the increasing use of TDCs is the eventual exhaustion
of the traditional vascular sites for creation of arteriove-
nous fistula in long-term hemodialysis patients who have
suffered multiple failed arteriovenous accesses.
Compared to arteriovenous accesses, TDCs are asso-
ciated with lower blood flows, increased incidence of lo-
cal and systemic infection, development of central ve-
nous stenosis and thrombosis, and increased morbidity
and mortality [1, 6, 7]. It is for these reasons that NKF-
DOQI vascular access guidelines have recommended
that all end-stage renal disease (ESRD) patients initiating
hemodialysis should be aggressively educated about the
risks and benefits associated with catheters, and strongly
encouraged to allow the creation of an arteriovenous
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fistula (AVF) where appropriate [8]. In keeping with this
focus, the National Vascular Access Improvement Initia-
tive (“Fistula First”) also mandates that whenever possi-
ble, an AVF should be placed in patients using tunneled
hemodialysis catheters [9].
The purpose of this study was to determine the impact
of aggressive vascular access education, vascular map-
ping, and endovascular interventions offered by inter-
ventional nephrologists, as well as the application of full
range of appropriate surgical techniques on the creation
of AVFs in patients consigned to TDCs.
METHODS
Out of a total of 355 ESRD patients from the three Uni-
versity of Miami chronic hemodialysis centers, 121 were
identified that had used a TDC for more than 3 months
without a future plan for surgical creation of an arteriove-
nous access, and were enrolled in this prospective anal-
ysis. Eighteen patients had been receiving dialysis using
a TDC for less than three months and failed to meet the
inclusion criteria.
A team approach composed of the primary nephrol-
ogist, vascular access nephrology nurses, nurse practi-
tioner, interventional nephrologist, and renal fellows on
the interventional service was employed. A slight change
in the traditional surgical venue was made. A surgeon
was selected who was committed to the principals of the
“Fistula First” project [9], was familiar with the impact
of the basic principles of vascular access on dialysis out-
comes, offered the full range of appropriate surgical ap-
proaches for AVF placement, including vein transposi-
tions, and was willing to work with the nephrology team
to provide optimal vascular access care. Regular com-
munication was established between the surgeon and the
nephrology team by telephone meetings.
Vascular access education
Based on NKF-DOQI guidelines [1], patients were ed-
ucated regarding vascular access types and their associ-
ated complications, including the risk of morbidity and
mortality. Specifically highlighted for TDCs were local
and systemic infectious complications, catheter-related
central vein stenoses and thromboses with consequent
preclusion of future arteriovenous access creation in the
upper extremities, the impact of low catheter flows on
dialysis adequacy, and the increased overall morbidity
and mortality. The AVF was highlighted as the best avail-
able access with the lowest incidence of complications.
Better access and patient survival for an AVF was empha-
sized. Patients were encouraged to request the creation
of an AVF at their appointment with the surgeon.
Vascular mapping
To investigate the possibility of creation of an arteri-
ovenous access, both venous and arterial evaluation was
undertaken by means of vascular mapping (VM).
Vein mapping using venography was offered and per-
formed by the interventional nephrologist. Briefly, after
obtaining informed consent, a peripheral vein on the dor-
sum of the hand was cannulated. Low osmolarity contrast
medium (Isovue 370; Bracco, Minneapolis, MN, USA)
(10–20 mL) diluted with 10 to 20 mL of normal saline
was injected through the cannula. Fluoroscopy was per-
formed using the pulse (15 frames per second) and road
map feature (15 frames per second). A tourniquet was
not applied to distend and enhance the size of the veins.
All angiograms utilized in this study were obtained using
a fluoroscopy machine (GE 9800, GE Medical Systems,
Milwaukee, WI, USA) calibrated for measurements us-
ing a radiopaque ruler. Images were obtained from the
wrist veins to the right atrium. The criteria used to de-
termine suitability of veins was based on a prior bench-
mark study [10], and included vein size of at least 2.5 mm,
absence of stenosis within the vein, and continuity with
downstream patent veins. Vein mapping was performed
on both upper extremities. Peripheral as well as central
veins were evaluated for all patients. A stenosis equal to
or exceeding 50% compared to normal adjacent vessel
was considered as significant stenosis based on K-DOQI
guidelines [1].
The arterial system was evaluated using the recommen-
dations delineated by the NKF-DOQI vascular access
guidelines [1]. A detailed physical examination of the ar-
terial system, including blood pressure, arterial pulses,
capillary refill, and the Allen test in both extremities
was performed as described previously by Beathard [11].
Specifically required were a blood pressure differential
of ≤20 mm Hg and a negative Allen test (patent palmar
arch). Neither arteriography nor Doppler ultrasound de-
termination were performed.
Upon conclusion of the venous imaging, the fluo-
roscopy monitor was placed in front of the patient for
viewing of the venography images. Using lay terminology,
the venography findings were described to the patients as
they were educated about possible site(s) for fistula cre-
ation. Patients found to have patent veins suitable for an
arteriovenous access were referred to the vascular sur-
geon. A detailed report was sent to the vascular surgeon
that included venogram images, as well as recommenda-
tions for possible site(s) of access creation. During phone
communications with the surgeon, the venogram images
were discussed, the need for arteriovenous access cre-
ation was emphasized, and the creation of an AVF was
requested in every case.
Postsurgical follow-up
After surgical creation of the arteriovenous access,
patients were followed carefully by the interventional
nephrology team. At one- to two-week intervals, physical
examination of the newly created access was performed
on each patient to assess the developmental progress
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Table 1. Demographics of the tunneled hemodialysis
catheter–consigned patients
Number of patients 121
Age years 47.9 ± 10.9
Gender
Women% 44%
Race/ethnicity
Hispanic 48 (40%)
African American 44 (36%)
Caucasian 18 (15%)
Haitian 11 (9%)
Cause of ESRD
Diabetic nephropathy 51 (42%)
Hypertension 46 (38%)
Glomerulonephritis 11 (9%)
HIV-associated nephropathy 7 (6%)
Lupus nephritis 4 (3%)
Polycystic kidney disease 2 (2%)
Data are mean ± SD.
of the arteriovenous access. Based on the physical
examination performed by interventional nephrologists,
if the fistula developed adequately and attained a di-
ameter of ≥0.4 cm, cannulation for dialysis was rec-
ommended. The cannulation was discussed with the
hemodialysis nurse taking care of the patient either by
telephone call or by examination of the patient with the
nurse. A simple question was asked of the nurse: “Can
this fistula be cannulated?” Once the arteriovenous ac-
cess was used successfully for three consecutive dial-
ysis sessions, the TDC was removed by interventional
nephrology.
Postsurgical interventions (percutaneous
salvage procedures)
Early failure was defined as a fistula that failed to de-
velop adequately to support dialysis after construction, or
failed within three months of its initial use. This was as-
sessed by physical examination. The application of phys-
ical examination to evaluate fistula failure was based
on a recent benchmark study [12]. Patients with early
failure were referred to the interventional team for a
salvage procedure. Salvage procedures included percu-
taneous balloon angioplasty, accessory vein ligation, and
sequential dilatation of stenotic lesions. The techniques
for these were used based on the previous descriptions by
Beathard et al [12]. All procedures were performed on an
outpatient basis and under local anesthesia and conscious
sedation.
RESULTS
Demographic characteristics of the patients are shown
in Table 1.
Out of the 121 TDC-consigned [8.3 ± 3.2 months (SD)]
patients, 86 (71%) agreed to proceed with vascular map-
ping and possible creation of arteriovenous access after
aggressive education regarding the types of vascular ac-
cesses and their associated complications and morbidity
and mortality. Of the 86 patients who agreed to have vas-
cular mapping, two subsets of patients were identified
(Fig. 1). Group I, those who had never had an arteriove-
nous access (N = 66; using TDC for 7.2 ± 1.8 months),
and group II, those who had had one or more previously
failed arteriovenous accesses and were now catheter de-
pendent (N = 20; using TDC for 12.3 ± 4.0 months).
In all 86 patients, the Allen test was negative, indicating
patent radial and ulnar arteries supplying the palmar arch
and the bilateral upper extremity blood pressure differ-
ential did not exceed ≥20 mm Hg. Capillary refill ranged
from 2 to 3 seconds, and brachial, ulnar, and radial pulses
were 2+ to 3+.
In group I (N = 66), 64 (97%) patients were found
to have adequate veins for arteriovenous fistula cre-
ation on venography (cephalic vein in the forearm and/or
arm and basilic vein) (Fig. 1). Out of the 64 patients, 7
(11%) refused surgery, and 57 (89%) were referred for
AVF creation. Of the 57 patients who proceeded with
surgery, 15 demonstrated adequate cephalic veins in the
forearm and received a radiocephalic fistula. Thirty-five
patients demonstrated an adequate cephalic vein in the
upper arm. All of these received a brachiocephalic fis-
tula. The remaining seven patients demonstrated only an
adequate basilic vein for AVF creation. Of these, three
received a transposed brachiobasilic fistula, and four had
a brachiobasilic graft inserted. Unilateral central venous
stenosis was seen in 9/66 (14%) patients. However, this
did not preclude the creation of an arteriovenous access
on the opposite side.
In group II (N = 20), 18 (90%) patients were found to
have veins available for fistula creation (forearm and arm
basilic veins = 2, arm basilic veins = 16), while two pa-
tients (10%) did not have veins suitable for AVF creation
and remained with catheters (Fig. 1). Three (17%) de-
ferred surgery. The remaining 15 (83%) received a trans-
posed basilic fistula (transposed radiobasilic = 2, trans-
posed brachiobasilic=13). Three (17%) patients in group
II demonstrated central venous blockage; one belonged
to the group that refused surgery. In the other two, central
venous blockage did not preclude surgery on the opposite
side.
Overall in group I, out of the 64 patients who were
found to have adequate veins for fistula creation, 53
(83%) received an AVF, four (6%) had an AVG, and
seven (11%) refused to undergo surgery (Fig. 1). In this
group, 41 (72%) patients (AVF = 38, AVG = 3) had the
arteriovenous access created contralateral to the TDC,
while 16 (28%) (AVF = 15, AVG = 1) had the access
constructed ipsilateral to the catheter. In group II, 15/20
(75%) received a transposed basilic fistula (Fig. 1). In
this group, nine (60%) patients had the arteriovenous
the fistula created contralateral to the TDC, while six
(40%) had an AVF constructed ipsilateral to the catheter.
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Vascular access education provided
N = 121
Agreed to undergo vascular mapping
N = 86
Two groups identified
Group I
(No previous AV access)
N = 66
Group II
(Failed previous accesses)
N = 20
Adequate veins for AV access creation
N = 64
Adequate veins for AV access creation
N =18
Patients deferred  surgery
N = 7
Referred  for AVF creation
N = 57
Patients deferred  surgery
N = 3
Referred  for AVF creation
N = 15
Types of AV accesses created Types of access created
RC AVF
N = 15
BC AVF
N = 35
TBB AVF
N = 3
TRB AVF
N = 2
TBB AVF
N = 13
AVG
N = 4
Fig. 1. Fate of 121 catheter-consigned patients who underwent vascular access education. Arteriovenous access (AV), arteriovenous fistula (AVF),
radiocephalic (RC), brachiocephalic (BC), transposed brachiobasilic (TBB), transposed radiobasilic (TRB), arteriovenous graft (AVG).
When asked, all the patients in this study denied having
been educated regarding vascular access types, their as-
sociated complications and morbidity and mortality, or
having been given the option of vascular mapping prior
to interaction with the interventional nephrology team.
In group I, 16/53 (30%) fistulas had early failure, (5/15
radiocephalic, 10/35 brachiocephalic, and 1 brachial-
basilic fistula) (Fig. 2). All except for one radiocephalic
fistula were successfully salvaged through interventional
treatment. The salvage procedures included percuta-
neous balloon angioplasty (N = 14) and PTA plus ac-
cessory vein obliteration procedure (N = 2) (Fig. 2). One
brachiocephalic fistula underwent a repeat PTA proce-
dure (sequential dilatation) to salvage the access (Fig. 2).
In group II, 8/15 (53%) transposed brachiobasilic fistulas
had early failure. All were successfully salvaged by the
interventional nephrologist except for one (Fig. 2). The
salvage procedure included percutaneous balloon angio-
plasty (N = 7) and accessory vein obliteration procedure
(N = 1). One brachiobasilic fistula (Fig. 2) needed a re-
peat angioplasty procedure (sequential dilatation).
Overall, 66/86 (77%) of the TDC-consigned patients
who underwent vein mapping achieved a functioning ar-
teriovenous fistula, while only 4/86 (5%) of the patients
received an AVG. In all of these cases (66 fistulas and 4
grafts), TDCs were removed by interventional nephrol-
ogy under local anesthesia after three consecutive suc-
cessful hemodialysis sessions though the arteriovenous
access. All 70 arteriovenous accesses are functional, with
a mean follow-up of 8.5 ± 3.6 SD months.
Cumulative procedure-related complications included
grade I hematoma (N = 2) during angioplasty that sealed
automatically, and did not require any specific interven-
tion other than manual pressure. One patient experi-
enced transient paresthesia in the cubital fossa after vein
ligation using the cut down technique that resolved after
six months. None of the patients suffered any complica-
tions during vein mapping or TDC removal procedures.
DISCUSSION
The vascular access options available to nephrol-
ogists caring for hemodialysis patients typically have
been limited by the availability of diagnostic and per-
cutaneous technologies and the repertoire of their
surgical colleagues. The advent of interventional nephrol-
ogy has widened the horizons of both diagnostic and
procedural options available for nephrologists to of-
fer their hemodialysis patients, particularly those who
had been consigned to tunneled catheters for receiving
dialysis therapy. This study demonstrates that patients
consigned to hemodialysis by means of percutaneous vas-
cular catheters may be excellent candidates for success-
ful placement of autologous arteriovenous native fistulas,
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Failed arteriovenous fistula
N = 24
Group I
N = 16
Group II
N = 8
Types of failed fistulaTypes of failed fistula
RC AVF
N = 5§
BC AVF
N = 10
TBB AVF
N = 1
PTA = 2
PTA + AVL = 2
PTA = 11 PTA = 1
TRB AVF
N = 2
TBB AVF
N = 6*
PTA = 2 PTA = 5∞
AVL = 1
Salvage proceduresSalvage procedures
Fig. 2. Fate of failed arteriovenous fistulas. Arteriovenous fistula (AVF), radiocephalic (RC), brachiocephalic (BC), transposed brachiobasilic
(TBB), transposed radiobasilic (TRB), percutaneous transluminal balloon angioplasty (PTA), accessory vein ligation (AVL). §, One radiocephalic
fistula could not be salvaged.€, Repeat angioplasty (sequential dilatation) was needed in one brachiocephalic fistula. ∗, One transposed brachiobasilic
fistula could not be salvaged. ∞, One transposed brachiobasilic fistula needed repeat PTA (sequential dilatation).
provided that both vascular access education highlighting
the impact on dialysis access type on morbidity and mor-
tality and a thorough preoperative vascular assessment
are performed. A no less important finding is that the
arteriovenous accesses placed in these clinical situations
often may require postoperative interventional salvage
procedures to achieve a functioning arteriovenous access.
Recent data have demonstrated that preoperative vas-
cular assessment utilizing ultrasonography or venogra-
phy is far superior to physical examination (inspection
of veins by naked eye using the tourniquet placed on
the upper arm) in evaluating vessels suitable for arte-
riovenous fistula creation [13–17]. Relying on the phys-
ical examination to assess the vascular system may re-
sult in exclusion of patients in whom venography actually
will demonstrate adequate veins for AVF creation. Allon
et al [13] documented a dramatic increase in arteriove-
nous fistula creation when preoperative vascular map-
ping using sonography was employed compared to the
traditional physical examination approach (preoperative
physical examination = 34%, preoperative sonographic
vascular mapping = 64%; P < 0.001). Indeed, using pre-
operative mapping approach, these investigators demon-
strated a doubling of the patients dialyzing successfully
with a fistula (preoperative physical examination = 16%,
preoperative sonographic vascular mapping = 34%; P <
0.001) [13]. Another study documented a significant im-
provement in arteriovenous fistula creation (from 14% to
63%), reduction in AVG placement (from 62% to 30%),
and reduction in tunneled hemodialysis catheters inser-
tion (from 24% to 7%) when preoperative mapping of the
arteries and veins was performed using Doppler duplex
ultrasonography [8]. These studies applied preoperative
vascular assessment by ultrasonography to the patients
initiating chronic hemodialysis [8, 13].
In contrast to the above-cited studies, we prospectively
identified hemodialysis patients who were consigned to
permanent long-term treatment by means of tunneled
catheters and provided vascular access counseling. Upon
our asking, all the patients in this study denied having
been educated regarding vascular access types, their as-
sociated complications and morbidity and mortality, or
having been given the option of vascular mapping prior
to interaction with interventional nephrology team. How-
ever, it is conceivable that some of these patients may
have been asked for access placement in passing. Vascular
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mapping was then performed by interventional nephrol-
ogy for the purpose of identifying vessels that might be
available for creation of arteriovenous accesses. Of 86
patients agreeing to vascular mapping, 80 patients (95%)
were found to have patent veins suitable for arteriove-
nous access placement. Only four patients (5%) were
found not to have suitable veins for placement of an
arteriovenous access and, therefore, were truly depen-
dent on tunneled catheters for hemodialysis therapy. It
is noteworthy that 94% of patients with no prior arteri-
ovenous accesses (64 of 66) had suitable veins, and that
90% of patients with previously failed arteriovenous ac-
cesses (18 of 20) had suitable veins, all basilic veins in the
latter cases (forearm + arm = 2, arm = 16). These find-
ings clearly demonstrate the value of vascular mapping in
detecting vessels suitable for arteriovenous access place-
ment, even in patients previously consigned to percuta-
neous catheters because of prior vascular access failures.
Indeed, these results virtually mandate the search for
patent veins suitable for arteriovenous access placement
in every patient dialyzing with a percutaneous catheter.
In this study, bilateral upper extremity venography (in-
cluding the side of the catheter) was performed in all pa-
tients. This was done to map all of the possible sites for
access creation. This also provided information that could
be used for future placement of a fistula. In contrast to
Silva et al [8], in the current study, outflow occlusion dur-
ing venography was not performed. Occluding the venous
outflow distends the veins and introduces the possibility
of overestimating the actual size of the vein. At the time
of fistula creation during surgery, outflow occlusion to dis-
tend the veins is not performed. In this context, it is con-
ceivable that a vein that appeared 2.5 mm on ultrasound
evaluation might actually be less than the sonographically
determined size, creating a dilemma at the time of surgery.
To help avoid the possibility of this scenario, we did not
perform outflow occlusion. Of interest, we did not find ev-
idence for arterial insufficiency to preclude AVF creation
in any of our cohort. Although Doppler ultrasound has
been highlighted to offer the advantage of arterial evalu-
ation, we find that physical examination provides ample
information for arteriovenous fistula creation. Indeed, for
arterial evaluation, NKF-DOQI guideline 2 recommends
that Doppler examination or arteriography should only
be performed in the presence of markedly diminished
arterial pulses on physical examination [9]. Further, the
Work Group concluded that arteriography is only rarely
required. Our approach was based on this recommenda-
tion. However, it is worth noting that this recommenda-
tion is opinion based.
Having discovered patent veins, the surgical challenge
is to successfully create a functioning arteriovenous ac-
cess suitable for hemodialysis therapy. A surgeon must
be willing to utilize a full range of appropriate surgical
approaches, including vein transpositions, to successfully
create an AVF, have a basic knowledge of the complica-
tions associated with dialysis access types, and be willing
to work as a team member with nephrologists. Using this
approach at our center, 68 of the 86 patients (79%) who
underwent vascular mapping received an arteriovenous
fistula. Of note, 18/68 (26%) required a vein transposition
(radiobasilic = 2, brachiobasilic = 16) to create an arteri-
ovenous fistula. Fifteen of the transposed fistulas were in
patients with prior failed vascular accesses. In this study,
only four patients received a brachiobasilic graft. All four
had a basilic vein; however, the decision to place a graft
was based on findings at the time of surgery.
Recently, the superiority of transposed fistulas has
been documented over arteriovenous grafts [18–25]. Al-
though transposition of the basilic vein to create an AVF
is a surgical procedure noted in the dialysis literature for
over 30 years [26], this has been a vastly underutilized
technique until very recently. The current study clearly
demonstrates that the basilic vein of the upper arm com-
monly is patent, even in the hemodialysis patient who has
had multiple failed vascular accesses. This finding is con-
sistent with the previous documentation that this vein is
present in over 95% of these patients [20, 25]. In com-
munities where the surgical repertoire does not include
the creation of autologous fistulas by means of basilic
vein transpositions, it is probable that a significant per-
centage of hemodialysis patients will have become per-
manently dependent on TDCs needlessly. Therefore, it
seems prudent to always undertake a search for patency
of the basilic vein before consigning a patient to perma-
nent dependence on a percutaneous vascular catheter.
The current report found a higher percentage of fistula
placement (79%) compared to 64% and 63% that was
reported by Allon [13] and Silva [8], respectively. The
organized team approach, a change to a surgeon who uti-
lized a full range of surgical techniques including vein
transpositions, referral for fistula only, aggressive input
and follow-up by the nephrology team, and the availabil-
ity of venographic images demonstrating the actual size
instead of distended veins might have been the reasons
for this difference. Is venography superior to sonographic
evaluation? To the best of our knowledge, there have not
been any randomized studies comparing venography and
vascular ultrasound mapping to establish the superiority
of one preoperative imaging technique over the other. In
the absence of such studies, it is difficult to report which
mapping technique is superior. Indeed, using a combina-
tion of preoperative noninvasive (Doppler ultrasound)
and invasive (venography and arteriography) techniques,
Huber et al [14] did demonstrate a higher percentage
of fistula creation (90%) than our study. One clear ad-
vantage of venography is direct imaging of the central
veins instead of indirect assessment provided by Doppler
evaluation. Alternatively, ultrasound offers the advan-
tage of noninvasive arterial evaluation. Regardless, both
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techniques offer a clear advantage over inspection of
veins by the naked eye using a tourniquet [8, 13].
This study demonstrates the error of the commonly
held perception that there is nothing to be done to save
the autologous arteriovenous fistula that fails to ma-
ture sufficiently to provide dialysis. Using percutaneous
balloon angioplasty and/or accessory vein obliteration
procedures, Beathard et al [12] provided evidence for
successful salvage of fistulas that had failed to mature
sufficiently to be able to sustain adequate hemodialysis.
In their study, out of the 100 patients with failed fistulas,
92% were able to initiate dialysis using the fistula after
percutaneous interventions by interventional nephrolo-
gists. Using this approach we were able to salvage a great
majority of failed fistulas. We elected to wait for four
weeks before fistula cannulation, even if the desired 0.4
cm size was achieved. This was done to allow for complete
resolution of postoperative edema and wound healing by
primary and secondary intentions, which generally takes
about four weeks to complete. We also took into consider-
ation the report by Rayner et al [27], which demonstrated
that cannulation of a fistula within two weeks of its con-
struction led to a higher failure rate.
Previous investigators have demonstrated a decline in
primary failure rate when preoperative vascular assess-
ment was undertaken [8]. We did not find a lower inci-
dence of early fistula failure in our analysis. The overall
early failure rate for fistulas in the current report was
35% (24 of 68 AVFs). Fifteen of the 50 (30%) nontrans-
posed (radiocephalic = 5 and brachiocephalic = 10) and
nine of the 18 transposed fistulas (50%) had early failure
[19, 23, 24]. Indeed, in their study, even with the appli-
cation of preoperative vascular mapping, Allon et al [13]
also failed to find an improvement in early fistula fail-
ure. In our study, the cohort with transposed fistulas, in
fact, had a higher early failure rate. The cause for this
higher failure rate in the transposed fistulas is unclear.
We speculate that the presence of multiple swing points
and utilization of the single stage transposition procedure
may have been responsible. However, to the best of our
knowledge, there have been no randomized studies com-
paring the failure rate between single-stage and two-stage
transposition of basilic vein for AVF creation. Of inter-
est, this report found the early failure rate to be higher
in women [58% (14/24)] than in men. This observation
is consistent with the findings of Miller [28], as well as
Gibson et al [29], who also reported a higher incidence
of early fistula failure in women.
Thirty-four percent of our 355 prevalent hemodialy-
sis patients had been receiving hemodialysis by means of
percutaneous vascular catheters. With the interventional
nephrology team approach, the catheter-consigned popu-
lation was reduced to 14%. The demographic characteris-
tics of the study patients did not reveal an overabundance
of groups that traditionally have been labeled as having
inadequate veins for AVF creation, specifically women,
the elderly, or patients with diabetes or diseases treated
long-term with steroids, such as lupus (Table 1). There
were no significant differences between the demographic
characteristics of patients who refused vascular map-
ping/surgery and those who received vascular mapping
and surgery. The age of the patients in our study is signifi-
cantly younger than the United States ESRD population.
This may be due to the fact that our center represents an
immigrant (Hispanic and Haitian) and inner city African
American population, which is not reflective of the larger
Medicare United States ESRD population. Prior to the
advent of our interventional nephrology program, most
of the patients dialyzing with vascular catheters would not
have been considered as candidates for an arteriovenous
vascular access. Indeed, none of these patients reported
having been approached with the possibility. This is not
an indictment of their nephrologist’s prior commitment
to optimizing their vascular health care, but rather a state-
ment regarding options that became available and acces-
sible with the advent of vascular access management by
nephrologists. Of note, 37% (45/121) of the patients re-
fused either vascular mapping (N = 35) or access surgery
(N = 10), even after full explanation of the complica-
tions, morbidity, and mortality associated with catheters.
We do not have an exact explanation of this refusal; how-
ever, painless dialysis with catheters and fear of surgery
may have been the culprits. Indeed, from the patient’s
perspective, pain has been the most common problem
during cannulation of an arteriovenous access [30].
CONCLUSION
While there has been much speculation regarding the
multiple reasons for the dependence on TDC and AVF
underutilization, the results of this study demonstrate
that an organized approach based upon a program uti-
lizing VA counseling, VM, application of a full range of
surgical techniques, and salvage procedures can be very
successful in providing optimum vascular access to the
catheter-dependent patient.
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